A Randomized Trial to Evaluate Efficacy and Safety of Intracavernosal Injection of Platelet-Rich Plasma Versus Phosphodiesterase Type-5 Inhibitors for Treatment of Erectile Dysfunction.

NCT05787769 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Erectile Dysfunction Following Radiation Therapy
Phosphodiesterase Inhibitor Adverse Reaction
Platelet- Rich Plasma (PRP)

Interventions

DRUG: P shot arm ( Autologous Platelet Rich Plasma)
DRUG: PDE5i arm

Sponsor

Mansoura University